Comparing the efficacy of Albuterol Nebulizer and Albuterol plus Budesonide Nebulizer in treatment of Respiratory Distress Syndrome
Phase 3
- Conditions
- Respiratory distress syndrome of newborn.Respiratory distress syndrome of newborn
- Registration Number
- IRCT2016111617413N22
- Lead Sponsor
- Vice chancellor for research, Pharmaceutical Sciences Branch, Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
birth weight between 1000-2500 gr; gestational age of less than 36 weeks; mechanical ventilation for at least two days; oxygen saturation of more than 30% after extubation; pH<7.2; PCO2>55; PaO2<50. Exclusion criteria: hemorrhagic lesions; congenital anomalies; chromosomal anomalies; early sepsis; death before 72 hours of age.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PH. Timepoint: before and after intervention. Method of measurement: Arterial Blood Gas Assessment.;Respiratory rate. Timepoint: before and after intervention. Method of measurement: one minute counting by nurse.;Blood Pressure. Timepoint: before and after intervention. Method of measurement: Monitoring System.;Oxygen Saturation. Timepoint: before and after intervention. Method of measurement: Pulse Oxymetry.
- Secondary Outcome Measures
Name Time Method